1st Quarter - Report

IPOLICY SOLUTIONS for SEMA4 (FORMERLY KNOWN AS MOUNT SINAI GENOMICS, INC. (D/B/A SEMA4))

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

No bill #, Verifying Accurate Leading-Edge IVCT Development (VALID) Act Draft Guidance: Developing and Labeling In vitro Companion Diagnostic Devices for a Specific Group or Class of Oncology Therapeutic Products

LobbyistCovered position, as disclosed
JENNIFER RACHEL LEIB Fellow, Senate Committee on Health, Education, Labor, and Pensions

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.